Engineering a GABA endowed with pharmacological CNS activity when given by an extracerebral route

Abstract : Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter physiologically active in the central nervous system (CNS), being synthesised and delivered by GABAergic neurons. It is, however, pharmacologically devoid of CNS activity when presented externally to brain because of limited blood-brain barrier diffusion and intensive breakdown by astrocyte GABA transaminase. We show herein that extracerebral administration may be, however, pharmacologically effective in controlling experimental convulsive attacks when GABA is submitted to sublimation under vacuum just before use. Though initially enigmatic because nuclear magnetic resonance (NMR) and infrared (IR) analyses identified the sublimation-derived compound to be the reference zwitterionic GABA, this observation was understood by showing that the reference and sublimated GABAs were monoclinic and tetragonal phases of GABA solid, respectively.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-artois.archives-ouvertes.fr/hal-00545967
Contributor : Wilfried Déplanques <>
Submitted on : Monday, December 13, 2010 - 1:48:26 PM
Last modification on : Friday, September 13, 2019 - 1:13:44 AM

Links full text

Identifiers

Citation

Joseph Vamecq, Yves Feutelais, Pierre Maurois, Mehrez Sghaier, Emma Dichi, et al.. Engineering a GABA endowed with pharmacological CNS activity when given by an extracerebral route. Medicinal Chemistry Research, Springer Verlag, 2009, 18 (4), pp.255-267. ⟨10.1007/s00044-008-9124-1⟩. ⟨hal-00545967⟩

Share

Metrics

Record views

191